| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3906417 | Urology | 2007 | 7 Pages |
Abstract
The results of our study have shown that combined mTOR and other upstream inhibitors have strong potential in the treatment of renal cell carcinoma.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Luciano J. Costa, Robert M. Gemmill, Harry A. Drabkin,